Last Updated: September 24, 2026

Details for Patent: 10,392,406


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,392,406 protect, and when does it expire?

Patent 10,392,406 protects XOFLUZA and is included in two NDAs.

This patent has eighty-six patent family members in thirty-nine countries.

Summary for Patent: 10,392,406
Title:Substituted polycyclic pyridone derivatives and prodrugs thereof
Abstract:The present invention provides the following compounds having anti-viral activity.
Inventor(s):Makoto Kawai
Assignee: Shionogi and Co Ltd
Application Number:US15/569,191
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,392,406
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 10,392,406

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Genentech Inc XOFLUZA baloxavir marboxil FOR SUSPENSION;ORAL 214410-001 Nov 23, 2020 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Genentech Inc XOFLUZA baloxavir marboxil FOR SUSPENSION;ORAL 214410-002 May 30, 2025 RX Yes No ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Genentech Inc XOFLUZA baloxavir marboxil FOR SUSPENSION;ORAL 214410-003 May 30, 2025 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Genentech Inc XOFLUZA baloxavir marboxil TABLET;ORAL 210854-001 Oct 24, 2018 DISCN Yes No ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Genentech Inc XOFLUZA baloxavir marboxil TABLET;ORAL 210854-002 Oct 24, 2018 AB RX Yes No ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Genentech Inc XOFLUZA baloxavir marboxil TABLET;ORAL 210854-003 Mar 18, 2021 AB RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,392,406

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2015-090909Apr 28, 2015
Japan2015-236844Dec 3, 2015
PCT Information
PCT FiledApril 27, 2016PCT Application Number:PCT/JP2016/063139
PCT Publication Date:March 11, 2016PCT Publication Number: WO2016/175224

International Family Members for US Patent 10,392,406

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3428170 ⤷  Start Trial LUC00198 Luxembourg ⤷  Start Trial
European Patent Office 3428170 ⤷  Start Trial C20210003 00390 Estonia ⤷  Start Trial
European Patent Office 4219508 ⤷  Start Trial 122024000036 Germany ⤷  Start Trial
European Patent Office 4219508 ⤷  Start Trial 301295 Netherlands ⤷  Start Trial
European Patent Office 4219508 ⤷  Start Trial 2024C/542 Belgium ⤷  Start Trial
European Patent Office 4219508 ⤷  Start Trial C20240038 Finland ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.